Potential Drug Target and Biomarker for Cell Wall Biology (G84232)

Target Name: MAF1

NCBI ID: G84232

MAF1

Potential Drug Target and Biomarker for Cell Wall Biology

MAF1, also known as homolog of yeast MAF1, is a protein that is expressed in the yeast Saccharomyces cerevisiae. It is a member of the MAF family, which is a group of proteins that are involved in the regulation of microbial cell wall biosynthesis.

The MAF1 protein has been identified as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and respiratory tract infections. This is because MAF1 plays a key role in the development and maintenance of the cell wall, which is a critical component of the cell structure and is involved in many cellular processes.

The cell wall is a complex structure that is composed of a variety of sugars and other carbohydrates that are bonded together in a highly ordered fashion. The cell wall helps to maintain the shape and structural integrity of the cell, and it also provides a barrier that helps to protect the cell from the outside world.

MAF1 is involved in the regulation of the composition and structure of the cell wall, as well as its biosynthesis. It does this by participating in a number of different processes that are involved in the production and maintenance of the cell wall.

One of the key functions of MAF1 is its role in the regulation of the synthesis of the peptidoglycan molecule, which is a key component of the cell wall. Peptidoglycan is the main structural component of the cell wall, and it helps to give the cell wall its strength and stability.

MAF1 is also involved in the regulation of the synthesis of other components of the cell wall, including the polymerization of cell wall peptides and the cross-linking of cell wall components.

Another function of MAF1 is its role in the regulation of the activity of the cell wall transferase enzyme, which is responsible for transferring the cell wall peptides from the cytoplasm to the cell wall. This enzyme is critical for the production of the cell wall and is highly sensitive to changes in the levels of the cell wall peptides.

MAF1 is also involved in the regulation of the activity of the cell wall maintenance enzyme, which is responsible for maintaining the stability of the cell wall. This enzyme is critical for the survival and growth of the yeast cell, and it is highly sensitive to changes in the levels of the cell wall maintenance factors.

In addition to its role in the regulation of cell wall biosynthesis, MAF1 is also involved in the regulation of the activity of several other enzymes that are involved in the cell wall. These include the enzymes involved in the synthesis of cell wall lipids and the enzymes involved in the regulation of cell wall permeability.

The potential drug target status of MAF1 is due to its involvement in the regulation of cell wall biosynthesis and the maintenance of the cell wall. This makes it an attractive target for drugs that are aimed at treating diseases that are characterized by the breakdown of the cell walls, such as cancer, neurodegenerative diseases, and respiratory tract infections.

In addition to its potential drug target status, MAF1 also has potential as a biomarker for a variety of diseases. The loss of cell wall integrity is often a hallmark of disease, and the levels of MAF1 in cells can be used as an indicator of the severity and progression of many diseases.

For example, high levels of MAF1 have been observed in cancer cells, and these levels have been associated with the development and progression of cancer. Similarly, MAF1 levels have been observed in neurodegenerative diseases, and these levels have been associated with the severity and progression of these conditions.

In addition to its potential clinical applications, MAF1 also has potential as a research tool for the study of cell wall biology. The structure and function of MAF1 can be studied using a variety of techniques, including biochemical, cellular, and structural studies.

Overall, MAF1 is a protein that is expressed in the yeast Saccharomyces cerevisiae that is involved in the regulation of the composition and structure of the cell wall, as well as its biosynthesis. It is a potential drug target and

Protein Name: MAF1 Homolog, Negative Regulator Of RNA Polymerase III

Functions: Plays a role in the repression of RNA polymerase III-mediated transcription in response to changing nutritional, environmental and cellular stress conditions to balance the production of highly abundant tRNAs, 5S rRNA, and other small non-coding RNAs with cell growth and maintenance (PubMed:18377933, PubMed:20233713, PubMed:20516213, PubMed:20543138). Also plays a key role in cell fate determination by promoting mesorderm induction and adipocyte differentiation (By similarity). Mechanistically, associates with the RNA polymerase III clamp and thereby impairs its recruitment to the complex made of the promoter DNA, TBP and the initiation factor TFIIIB (PubMed:20887893, PubMed:17505538). When nutrients are available and mTOR kinase is active, MAF1 is hyperphosphorylated and RNA polymerase III is engaged in transcription. Stress-induced MAF1 dephosphorylation results in nuclear localization, increased targeting of gene-bound RNA polymerase III and a decrease in the transcriptional readout (PubMed:26941251). Additionally, may also regulate RNA polymerase I and RNA polymerase II-dependent transcription through its ability to regulate expression of the central initiation factor TBP (PubMed:17499043)

The "MAF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets